CI&T, Inc. Class A CINT 深 沪
等待开盘 05-27 09:30:00 美东时间
3.22
-0.110
-3.30%
华盛通- 最 高3.49
- 今 开3.38
- 成交量 27.27万股
- 最 低 3.215
- 昨 收 3.33
- 总市值 4.33亿
- 52周最高 6.1403
- 市盈率 静 10.58
- 换手率 0.20%
- 52周最低 3.215
- 委 比 0.00%
- 总股本 1.35亿
- 历史最高 22.50
- 量 比 3.49
- 振 幅 8.26%
- 历史最低 3.215
- 每 手 1
- 风险率 0.59%
个股概要
财务分析
公司资料
相关新闻
分红派息
- 分时图
- 日k
- 周k
- 月k
相关新闻
更多美股大行评级 | 富国银行上调英伟达目标价从265美元升至315美元；Alamar、AEVEX获多家大行首予“买入”评级
今日重点评级关注：Needham：维持Artiva Biotherapeutics"买入"评级，目标价从18美元升至41美元；HC Wainwright & Co.：维持SAB Biotherapeutics"买入"评级，目标价从7美元升至10美元
05-13 11:46
Wedbush Maintains Outperform on CI&T, Lowers Price Target to $7
Wedbush analyst Steven Wahrhaftig maintains CI&T (NYSE:CINT) with a Outperform and lowers the price target from $9 to $7.
05-12 21:20
CI&T Raises FY2026 Sales Guidance from $548.000M-$568.000M to $555.800M-$575.300M vs $561.409M Est
CI&T (NYSE:CINT) raises FY2026 sales outlook from $548.000 million-$568.000 million to $555.800 million-$575.300 million vs $561.409 million estimate.
05-12 04:17
CI&T Q2 Revenue expected to be more than $140.000M vs $138.317M Est
CI&T (NYSE:CINT) Q2 Revenue expected to be more than $140.000M vs $138.317M Est
05-12 04:17
CI&T Q1 Adj. EPS $0.08 Misses $0.09 Estimate, Sales $136.608M Beat $134.678M Estimate
CI&T (NYSE:CINT) reported quarterly earnings of $0.08 per share which missed the analyst consensus estimate of $0.09 by 11.11 percent. This is a 14.29 percent increase over earnings of $0.07 per share from the same
05-12 04:17
Earnings Scheduled For May 11, 2026
Companies Reporting Before The Bell • United Parks & Resorts (NYSE:PRKS) is...
05-11 19:11
Shares of companies in the broader tech sector are trading lower amid possible sympathy with ServiceNow and IBM.
Shares of companies in the broader tech sector are trading lower amid possible ...
04-24 03:45
美股大行评级 | 小摩上调Lumentum控股目标价从565美元升至950美元；大小摩齐上调美国铝业目标价
今日重点评级关注：Ascendiant Capital：维持RenovoRx"买入"评级，目标价从13美元升至13.5美元；Ascendiant Capital：维持Lucid Diagnostics"买入"评级，目标价从8.25美元升至9美元
04-10 18:27
Wedbush Assumes CI&T at Outperform, Announces Price Target of $9
Wedbush analyst Steven Wahrhaftig assumes CI&T (NYSE:CINT) with a Outperform rating and announces Price Target of $9.
04-09 20:47
美股大行评级 | 潜在涨幅101%！甲骨文获花旗升目标价至320美元，维持"买入"评级
今日重点评级关注：Freedom Capital Markets：维持LifeMD"买入"评级，目标价从8美元升至10美元；Chardan Capital：维持Opus Genetics"买入"评级，目标价从9美元升至11美元
03-13 09:59
